Rodriguez-Nunez, O., Perianez-Parraga, L., Oliver, A., Munita, J., Bote, A., Gasch, O., . . . Soriano, A. (2019). Higher MICs (> 2 mg/L) Predict 30-Day Mortality in Patients With Lower Respiratory Tract Infections Caused by Multidrug- and Extensively Drug-Resistant Pseudomonas aeruginosa Treated With Ceftolozane/Tazobactam.
Citación estilo ChicagoRodriguez-Nunez, O., et al. Higher MICs (> 2 Mg/L) Predict 30-Day Mortality in Patients With Lower Respiratory Tract Infections Caused By Multidrug- and Extensively Drug-Resistant Pseudomonas Aeruginosa Treated With Ceftolozane/Tazobactam. 2019.
Cita MLARodriguez-Nunez, O., et al. Higher MICs (> 2 Mg/L) Predict 30-Day Mortality in Patients With Lower Respiratory Tract Infections Caused By Multidrug- and Extensively Drug-Resistant Pseudomonas Aeruginosa Treated With Ceftolozane/Tazobactam. 2019.